O‘TKIR IKKILAMCHI PERITONITDA REGIONAR LIMFA TUGUNLARINING IMMUNOGISTOKIMYOVIY XUSUSIYATLARI
DOI:
https://doi.org/10.5281/zenodo.23734278Keywords:
mezenterial limfa tuguni, o‘tkir ikkilamchi peritonit, immunogistokimyo, CD3, CD4, CD20, CD68, limfotsitlar kamayishi, ikkilamchi immun tanqislikAbstract
Maqsad. O‘tkir ikkilamchi peritonitdan vafot etgan 18–45 yoshli shaxslarda mezenterial limfa tugunlarining CD3, CD4, CD20 va CD68 markerlari bo‘yicha immunogistokimyoviy xususiyatlarini baholash. Material va usullar. Respublika patologik anatomiya markazida 2018–2023-yillarda o‘tkir ikkilamchi peritonitdan vafot etgan 131 nafar shaxsning autopsiya materiallari retrospektiv o‘rganildi. Qiyoslash uchun tizimli yallig‘lanishsiz, yurak ishemik kasalligidan vafot etgan 15 nafar shaxsning materiallari sifat jihatidan me’yoriy namuna sifatida olindi. Parafin bloklari yetarli darajada saqlangan 33 ta mezenterial limfa tuguni namunasida CD3, CD4, CD20 va CD68 markerlari yordamida immunogistokimyoviy tekshiruv (DAB xromogeni) bajarildi. Ekspressiya 0–3 ballik tartibli shkala bo‘yicha baholandi. Natijalar. Parakortikal CD3/CD4 T-limfotsitar paneli 21 ta holatda (63,6%; 95% ID 46,6–77,8) past pozitiv, 12 ta holatda (36,4%; 95% ID 22,2–53,4) negativ bo‘lib, o‘rtacha ball 0,64±0,49 ni tashkil etdi. CD68-pozitiv makrofaglar 27 ta holatda (81,8%; 95% ID 65,6–91,4) o‘rtacha pozitiv, 6 ta holatda (18,2%) past pozitiv aniqlandi; o‘rtacha ball 1,82±0,39 ni tashkil etdi. CD20 B-limfotsitlari baholangan 32 ta holatning 21 tasida (65,6%) negativ, 11 tasida (34,4%) past yoki o‘rtacha pozitiv bo‘ldi; o‘rtacha ball 0,34±0,48 ni tashkil etdi. Umumiy hisobda, 33 ta holatning 32 tasida (97,0%; 95% ID 84,7–99,5) CD20 ekspressiyasi kamaygan yoki yo‘qolgan. Xulosa. O‘tkir ikkilamchi peritonitda mezenterial limfa tugunlaridagi T- va B-limfotsitlar populyatsiyalari bir vaqtda kamayishi, makrofagal reaksiya esa kompensator tarzda kuchayishi kuzatiladi. Ushbu manzara ikkilamchi immun tanqislikning morfologik ifodasi bo‘lishi mumkin hamda limfa tugunlarining drenaj va to‘siq funksiyalari buzilganini ko‘rsatishi mumkin.References
1. Rajabaleyan, P., Kaalby, L., Deding, U., Al-Najami, I., & Ellebæk, M. B. (2025). Mortality in patients with secondary peritonitis treated by primary closure or vacuum-assisted closure: nationwide register-based cohort study. BJS Open. 2025;9(6). doi:10.1093/bjsopen/zraf118. nationwide register-based cohort study. BJS Open. 2025;9(6). https://doi.org/10.1093/bjsopen/zraf118
2. Ra, J. H., Rattan, R., Patel, N. J., Bhattacharya, B., Butts, C. A., Gupta, S., et al. (2023). Duration of antimicrobial treatment for complicated intra-abdominal infections after definitive source control: a systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg, 95(4), 603–612. https://doi.org/10.1097/TA.0000000000003998
3. Rebelo, A., Schlicht, L., Kleeff, J., Michalski, C. W., & Heckler, M. (2023). Carbapenem antibiotics versus other antibiotics for complicated intra-abdominal infections: a systematic review and patient-level meta-analysis of randomized controlled trials. J Gastrointest Surg, 27(6), 1208–1215. https://doi.org/10.1007/s11605-023-05651-7
4. Wang, Z., Zhang, W., Chen, L., Lu, X., & Tu, Y. (2024). Lymphopenia in sepsis: a narrative review. Crit Care. 2024;28(1):315. doi:10.1186/s13054-024-05099-4. 13054–024. https://doi.org/10.1186/s13054-024-05099-4
5. Huang, S., Liu, D., Sun, J., Zhang, H., Zhang, J., Wang, Q., et al. (2022). Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells. Mol Ther, 30(3), 1227–1238. https://doi.org/10.1016/j
6. Huang, S., Liu, D., Han, L., Deng, J., Wang, Z., Jiang, J., et al. (2024). Decoding the potential role of regulatory T cells in sepsis-induced immunosuppression. Eur J Immunol. 2024;54(5). doi:10.1002/eji.202350730. https://doi.org/10.1002/eji.202350730
7. Gao, Q., Teng, Y., Zhu, L., Zhang, W., & Li, Z. (2025). The immunosuppressive mechanisms induced by sepsis and the corresponding treatment strategies. Front Immunol. 2025;16:1643194. doi:10.3389/fimmu.2025.1643194. https://doi.org/10.3389/fimmu.2025.1643194
8. Jiang, Y., Gao, S., Li, X., Sun, H., Wu, X., Gu, J., et al. (2025). Myeloperoxidase-anchored ENO1 mediates neutrophil extracellular trap DNA to enhance Treg differentiation via IFITM2 during sepsis. J Clin Invest. 2025;135(21). doi:10.1172/JCI183541. https://doi.org/10.1172/JCI183541
9. Xu, L., Wei, C., Chen, Y., Wu, Y., Shou, X., Chen, W., et al. (2022). IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection. Nat Commun. 2022;13(1):6881. doi:10.1038/s41467-022-34660-4. 41467–022. https://doi.org/10.1038/s41467-022-34660-4
10. Gao, X., Cai, S., Li, X., & Wu, G. (2025). Sepsis-induced immunosuppression: mechanisms, biomarkers and immunotherapy. Front Immunol. 2025;16:1577105. doi:10.3389/fimmu.2025.1577105. mechanisms. https://doi.org/10.3389/fimmu.2025.1577105
11. Liu, D., Huang, S. Y., Sun, J. H., Zhang, H. C., Cai, Q. L., Gao, C., et al. (2022). Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56. doi:10.1186/s40779-022-00422-y. mechanisms. https://doi.org/10.1186/s40779-022-00422-y
12. Abdreshov, S. N., Demchenko, G. A., Gorchakov, V. N., Yessenova, M. A., & Yeshmukhanbet, A. N. (2024). Reactive changes in lymph node structure in peritonitis and during treatment with a new antibiotic. Bull Exp Biol Med, 177(6), 792–796. https://doi.org/10.1007/s10517-024-06269-8
13. Bourne, J. H., Beristain-Covarrubias, N., Zuidscherwoude, M., Campos, J., Di, Y., Garlick, E., et al. (2021). CLEC-2 prevents accumulation and retention of inflammatory macrophages during murine peritonitis. Front Immunol. 2021;12:693974. doi:10.3389/fimmu.2021.693974. https://doi.org/10.3389/fimmu.2021.693974
14. Trevelin, S. C., Pickering, S., Todd, K., Bishop, C., & Pitcher, M. (2022). Garrido Mesa J, et al. Disrupted Peyer’s patch microanatomy in COVID-19 including germinal centre atrophy independent of local virus. Front Immunol. 2022;13:838328. doi:10.3389/fimmu.2022.838328. https://doi.org/10.3389/fimmu.2022.838328

